Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide added to Basal Insulin in Type 2 Diabetes
NCT01617434Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01617434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617434.